powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1104053438
Daniel Sherbenou
MD, PHD
Hematopoietic Cell Transplantation and Cellular Therapy
Aurora,
CO
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
Healthparse Signals
Monitor this provider for changes — dated NPI change events
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (5)
CCN 060022
Hospital
CCN 060024
Hospital
CCN 060128
Hospital
CCN 060129
Hospital
CCN 060132
Hospital
PRESCRIBING · PART D · 2024
Total Rx claims
922
Beneficiaries
—
Total drug cost
$7.1M
Distinct drugs
22
Brand share
32.0%
Top prescribed drugs
Acyclovir
193 claims
Lenalidomide
162 claims
Lenalidomide
152 claims
Pomalidomide
73 claims
Oxycodone Hcl
28 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
216
Unique beneficiaries
—
Total services
476
Distinct HCPCS
4
Medicare payment
$50K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 11 Hematopoietic Cell Transplantation and Cellular Therapy providers in CO — above median (cohort median 498).
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$13K
Payment records
10
By payment type
Consulting Fee
$12K
Travel and Lodging
$730
Food and Beverage
$411
Top paying entities
Consulting Fee
$12K
Travel and Lodging
$730
Food and Beverage
$411
